Novabay(NBY)05-10 04:25
$Novabay(NBY)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-24-015679 Act: 34 Size: 10 MB 网页链接查看全文
智通财经APP获悉,美股周一盘前,NovaBay(NBY.US)发布了2019Q2财报,该生物制药公司专注于将 Avenova 商业化用于国内眼部护理市场。 根据财报,期内,公司净销售额为180万美元;Avenova销售额为160万美元,环比增长9%。 该公司总裁兼首... 网页链接
格隆汇6月11日丨NovaBay(NBY)今日盘前涨39.03%,报6.31美元,昨日大涨874.84%。NovaBay是一家专注眼部护理市场的生物制药公司,专注于其非抗生素抗感染产品的商业化和开发,以满足全球局部抗感染市场尚未得到满足的治疗需求,其主推产品之一... 网页链接
5月10日Novabay制药(股票代码:NBY)公布财报,公告显示公司2018财年第一财季净利润为-215.00万美元,同比增长46.4%;营业收入为294.70万美元,同比下跌20.37%。 NovabayPharmaceutic ... 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 美东时间 2015-11-13 08:30 Q3 2015 NovaBay Pharmaceuticals Inc Earnings Call 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 美东时间 2015-11-13 09:00 Before Open:NOVABAY PHARMAC Earning Release 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 美东时间 2015-11-13 09:00 Before Open:NOVABAY PHARMAC Earning Release 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 8-K - Current report Filed: 2015-10-27 AccNo: 0001437749-15-018932 Size: 785 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.03: Material Modifications to Rights of Security HoldersItem 8.01: Other EventsItem 9.01: Financial St...
$NOVABAY PHARMACEUTICALS INC(NBY)$ UPLOAD [Cover] - SEC-generated letter Filed: 2015-09-03 AccNo: 0000000000-15-044367 Size: 36 KB 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ UPLOAD [Cover] - SEC-generated letter Filed: 2015-08-28 AccNo: 0000000000-15-043452 Size: 158 KB 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ CORRESP [Cover] - Correspondence Filed: 2015-08-31 AccNo: 0001437749-15-016639 Size: 31 KB 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2015-10-26 AccNo: 0001437749-15-018864 Size: 646 KB 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2015-10-23 AccNo: 0001437749-15-018798 Size: 645 KB 网页链接
$NOVABAY PHARMACEUTICALS INC(NBY)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2015-10-22 AccNo: 0001437749-15-018743 Size: 652 KB 网页链接